Intuitive Surgical Inc (ISRG)

248.98
-5.70(-2.24%)
After Hours
249.40
+0.42(+0.17%)
- Real-time Data
  • Volume:
    1,328,770
  • Day's Range:
    248.24 - 252.97
  • 52 wk Range:
    180.07 - 308.97

ISRG Overview

Prev. Close
254.68
Day's Range
248.24-252.97
Revenue
6.22B
Open
251.76
52 wk Range
180.07-308.97
EPS
3.72
Volume
1,328,770
Market Cap
87.99B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,918,184
P/E Ratio
64.39
Beta
1.38
1-Year Change
-12.86%
Shares Outstanding
353,384,570
Next Earnings Date
Apr 20, 2023
What is your sentiment on Intuitive Surgical?
or
Market is currently closed. Voting is open during market hours.

Intuitive Surgical Inc News

Intuitive Surgical Inc Analysis

Intuitive Surgical Inc Company Profile

Intuitive Surgical Inc Company Profile

Intuitive Surgical, Inc. develops, manufactures, and markets the da Vinci surgical system and the Ion endoluminal system. The Company's products and related services enable physicians and healthcare providers to access minimally invasive care. The systems consist of a surgeon console or consoles, a patient-side cart, a vision system, and proprietary instruments and accessories. Its da Vinci products consist of five categories, such as da Vinci surgical systems, da Vinci instruments and accessories, da Vinci Stapling, da Vinci Energy, and da Vinci Vision, including Firefly Fluorescence imaging systems and da Vinci Endoscopes. It also provides a suite of systems, learning, and services offerings. Its Ion endoluminal system extends its commercial offerings beyond surgery into diagnostic procedures, enabling minimally invasive biopsies in the lung. Its services include readiness support, maintenance support, OR consulting, customer hospital analytics, and market consulting optimization.

Read More

Analyst Price Target

Average278.29 (+11.77% Upside)
High325.00
Low215.00
Price248.98
No. of Analysts17
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts Consensus

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellStrong SellStrong SellSellBuy
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellNeutral
SummaryStrong SellStrong SellStrong SellStrong SellNeutral
  • All above 70$ is expensive ! So short
    1
    • 256
      0
      • 260
        1
        • 197
          1
          • 90usd in July
            4
            • bought @216
              0
              • 300 to 210 in one month
                1
                • $200. AllIn
                  0
                  • What happened?
                    0
                    • On the conference call to discuss the results, management acknowledged the ongoing challenges related to the pandemic, which has resulted in order delays and patients continuing to postpone medical procedures. Management revised its guidance for procedure growth to a range of 12% to 16% for the full year, up from its previous guidance range of 11% to 15%. However, the company also acknowledged that its forecast "continues to reflect the uncertainty associated with the course of the pandemic," and that supply chain disruptions could further exacerbate the situation.
                      0
                    • according to The Motley Fool.
                      1
                  • 259
                    0